David Thomson

accessibility text

Name

David Thomson

Job title

Consultant Clinical Oncologist

Email Address

b.birchenough@nhs.net

Phone number

0161 446 8457

Qualifications

MA (Oxon.) BMBCh PGCME MD MRCP FRCR

Specialities

Head and neck

Started at The Christie (Year)

2009

Responsibilities

  • Head and neck oncology; treating patients with intensity-modulated radiotherapy, proton beam therapy, systemic therapies
  • MAHSC Honorary Chair and Professor at the University of Manchester
  • Honorary Clinical Professor of Oncology at the University of Liverpool
  • Clinical Lead for Head at Neck Cancer at the NHS Greater Manchester Cancer Alliance
  • Clinical Lead for Research at the NHS Greater Manchester Cancer Alliance

Professional biography

Professor David Thomson has a substantial national and international reputation in his field of head and neck oncology. He qualified from Oxford University Medical School in 2004, with a first-class honours degree, and has a Doctor of Medicine research degree from the University of Manchester. He is an honorary MAHSC Chair and Professor at the University of Manchester and Honorary Clinical Professor of Oncology at the University of Liverpool. He is the clinical lead for head and neck cancer in Greater Manchester (since 2018) and for the head and neck team at The Christie.

Professor Thomson has co-authored national and international guidelines for the treatment of head and neck cancer. He was an invited expert reviewer for the American and European Radiation Societies (ASTRO and ESTRO) guidelines for the treatment of oropharyngeal and nasopharyngeal cancers. He led for ESTRO on the expert international consensus guidance for the management of head and neck cancer during the COVID-19 pandemic. He is a member of the NHS England national proton commissioning panels for head and neck cancer and exceptional indications (since 2019).

He is also the NHS Greater Manchester Cancer Clinical Lead for Research (since 2022), and is Chief Investigator for major late phase multi-centre head and neck cancer clinical trials. He has given numerous invited talks on the treatment of head and neck cancer, has published work in high impact journals including Lancet Oncology and Journal of Clinical Oncology, and served as associate editor for the International Journal of Radiation Oncology Biology Physics (2020 to 2024).

Research Interest

Advanced radiotherapy technologies and adaptation; proton beam therapy; salivary gland cancers; tumour hypoxia modification; clinical trials

Educational Interests

Postgraduate medical education; radiotherapy quality assurance

Publications

The Christie Private Care

Dr. Thomson also practises privately at The Christie Private Care